Author Archives: Ted Nuyten

Immunotec Q2 Sales Up 28% To $25 Million

By Ted Nuyten Immunotec Inc. (TSX VENTURE:IMM), a direct-to-consumer company and leader in the nutritional industry (the “Company” or “Immunotec”), today announced its second quarter financial results for Fiscal 2016. All amounts in this press release are denominated ...

Read More »